StockStory.org on MSN
PODD Q4 deep dive: Type 2 diabetes expansion and innovation drive outperformance
Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2025 results , with sales up 31.2% year on year to $783.8 million. The company expects next quarter’s revenue to be around $716 ...
(Photo by Kirk Mckoy/Los Angeles Times via Getty Images) When it comes to surgical innovation, Intuitive Surgical (NASDAQ: ISRG) often dominates investor attention. But Insulet Corporation (NASDAQ: ...
We came across a bullish thesis on Insulet Corporation on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on PODD. Insulet Corporation’s share was trading at ...
$PODD insiders have traded $PODD stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales. Here’s a ...
$PODD insiders have traded $PODD stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales. Here’s a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results